Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: a qualitative study exploring the …
O Jolayemi, LM Bogart, ED Storholm… - PloS one, 2022 - journals.plos.org
Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for
people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in …
people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in …
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic
ZW Howe, S Norman, AF Lueken… - … : The Journal of …, 2021 - Wiley Online Library
Abstract Cabotegravir/rilpivirine (CAB/RPV) was recently approved by the US Food and
Drug Administration (FDA) as the first complete parenteral antiretroviral (ART) regimen for …
Drug Administration (FDA) as the first complete parenteral antiretroviral (ART) regimen for …
Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or …
L Fletcher, SAB Burrowes, GK Khan, L Sabin… - Harm Reduction …, 2023 - Springer
Introduction Adherence to daily oral antiretroviral therapy (ART) and regular clinic
appointments can be challenging for individuals who experience adverse social …
appointments can be challenging for individuals who experience adverse social …
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care …
Background Long-acting injectable antiretroviral therapy (LA ART) has been shown to be
non-inferior to daily oral ART, with high patient satisfaction and preference to oral standard …
non-inferior to daily oral ART, with high patient satisfaction and preference to oral standard …
Considerations for long-acting antiretroviral therapy in older persons with HIV
People with HIV (PWH) can now enjoy longer, healthier lives due to safe and highly effective
antiretroviral therapy (ART), and improved care and prevention strategies. New drug …
antiretroviral therapy (ART), and improved care and prevention strategies. New drug …
Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users
L Slama, R Porcher, F Linard, C Chakvetadze… - BMC infectious …, 2023 - Springer
Background The use of long acting injectable (LAA) antiretroviral drugs may be an
alternative option for HIV treatment and prevention. Our study focused on patient …
alternative option for HIV treatment and prevention. Our study focused on patient …
Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system
Background Long-acting injectable cabotegravir plus rilpivirine (LAI CAB/RPV) has several
potential benefits over daily oral formulations for HIV treatment, including the potential to …
potential benefits over daily oral formulations for HIV treatment, including the potential to …
“This Is Actually a Really Unique Moment in Time”: Navigating Long-Acting HIV Treatment and HIV Cure Research with Analytical Treatment Interruptions—A …
Advancements in long-acting (LA) HIV treatment and cure research with analytical treatment
interruptions (ATIs) have generated important scientific and implementation questions …
interruptions (ATIs) have generated important scientific and implementation questions …
Implications of long-acting antiretrovirals (LAARVs) for HIV treatment in Sub-Saharan Africa
E Kokori, G Olatunji, IJ Ogieuhi, TC Olusakin… - Discover Public …, 2024 - Springer
Abstract Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome
(AIDS) represent a global public health challenge that has persisted for decades. While …
(AIDS) represent a global public health challenge that has persisted for decades. While …
[PDF][PDF] Oluwadamilola Jolayemi ID*, Laura M. Bogart2☯, Erik D. Storholm2, 3☯, David Goodman-Meza ID 4☯, Elena Rosenberg-Carlson1☯, Rebecca Cohen5, Uyen …
RJ Landovitz - pdfs.semanticscholar.org
Long-acting injectable (LAI) antiretroviral therapy (ART) is a novel HIV treatment option for
people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in …
people with HIV. The first LAI ART regimen for HIV treatment received regulatory approval in …